Cargando…

A Randomized Controlled Trial to Compare Preemptive Analgesic Efficacy and Safety of Pregabalin and Gabapentin for Succinylcholine-Induced Myalgia

BACKGROUND: Succinylcholine is a drug of choice for rapid induction of anesthesia but produces postoperative myalgia. Preemptive analgesia is intended to decrease perception of pain before exposure to painful stimuli. Pregabalin and gabapentin, analogs of the inhibitory neurotransmitter gamma aminob...

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, Prachi, Bhosale, Uma A., Soundattikar, Girish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676998/
https://www.ncbi.nlm.nih.gov/pubmed/31413432
http://dx.doi.org/10.4103/nmj.NMJ_9_19
_version_ 1783440865253916672
author Jain, Prachi
Bhosale, Uma A.
Soundattikar, Girish
author_facet Jain, Prachi
Bhosale, Uma A.
Soundattikar, Girish
author_sort Jain, Prachi
collection PubMed
description BACKGROUND: Succinylcholine is a drug of choice for rapid induction of anesthesia but produces postoperative myalgia. Preemptive analgesia is intended to decrease perception of pain before exposure to painful stimuli. Pregabalin and gabapentin, analogs of the inhibitory neurotransmitter gamma aminobutyric acid, are effective in several models of neuropathic pain, incisional, inflammatory, and formalin-induced injury. However, the data available on their preemptive analgesic efficacy in succinylcholine myalgia are sparse. This study was designed to compare the preemptive analgesic efficacy and safety of pregabalin and gabapentin. MATERIALS AND METHODS: This randomized clinical trial included 120 surgical patients of either sex, between 18 and 70 years, and of American Society of Anesthesiologists-I/II grade. Patients were randomly allocated to control and test groups; received respective treatments 30 min before induction of anesthesia. Myalgia and pain scores were recorded using the myalgia scale and visual analog/facial rating scale at awakening at 6, 12, 18, and 24 h, respectively. Postoperative analgesic requirement over 24 h was recorded. Data were analyzed using OpenEpi (Andrew G. Dean and Kevin M. Sullivan, Atlanta, GA, USA) statistical softwares. RESULTS: Significantly lower pain scores were observed in the pregabalin group at 6, 12, and 24 h, and in gabapentin group at 24 h as compared to control and placebo (P < 0.05). They were however found to be equianalgesic when compared to each other (P > 0.05). Pregabalin-treated patients were more comfortable throughout with significantly less postoperative myalgia and analgesic requirement (P < 0.05). CONCLUSIONS: Results strongly suggest the preemptive analgesic efficacy of a single oral dose of pregabalin and gabapentin over diclofenac in postoperative myalgia and pain management. However, on the basis of safety profile, pregabalin may be preferred over gabapentin in succinylcholine-induced myalgia.
format Online
Article
Text
id pubmed-6676998
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-66769982019-08-14 A Randomized Controlled Trial to Compare Preemptive Analgesic Efficacy and Safety of Pregabalin and Gabapentin for Succinylcholine-Induced Myalgia Jain, Prachi Bhosale, Uma A. Soundattikar, Girish Niger Med J Original Article BACKGROUND: Succinylcholine is a drug of choice for rapid induction of anesthesia but produces postoperative myalgia. Preemptive analgesia is intended to decrease perception of pain before exposure to painful stimuli. Pregabalin and gabapentin, analogs of the inhibitory neurotransmitter gamma aminobutyric acid, are effective in several models of neuropathic pain, incisional, inflammatory, and formalin-induced injury. However, the data available on their preemptive analgesic efficacy in succinylcholine myalgia are sparse. This study was designed to compare the preemptive analgesic efficacy and safety of pregabalin and gabapentin. MATERIALS AND METHODS: This randomized clinical trial included 120 surgical patients of either sex, between 18 and 70 years, and of American Society of Anesthesiologists-I/II grade. Patients were randomly allocated to control and test groups; received respective treatments 30 min before induction of anesthesia. Myalgia and pain scores were recorded using the myalgia scale and visual analog/facial rating scale at awakening at 6, 12, 18, and 24 h, respectively. Postoperative analgesic requirement over 24 h was recorded. Data were analyzed using OpenEpi (Andrew G. Dean and Kevin M. Sullivan, Atlanta, GA, USA) statistical softwares. RESULTS: Significantly lower pain scores were observed in the pregabalin group at 6, 12, and 24 h, and in gabapentin group at 24 h as compared to control and placebo (P < 0.05). They were however found to be equianalgesic when compared to each other (P > 0.05). Pregabalin-treated patients were more comfortable throughout with significantly less postoperative myalgia and analgesic requirement (P < 0.05). CONCLUSIONS: Results strongly suggest the preemptive analgesic efficacy of a single oral dose of pregabalin and gabapentin over diclofenac in postoperative myalgia and pain management. However, on the basis of safety profile, pregabalin may be preferred over gabapentin in succinylcholine-induced myalgia. Wolters Kluwer - Medknow 2019 /pmc/articles/PMC6676998/ /pubmed/31413432 http://dx.doi.org/10.4103/nmj.NMJ_9_19 Text en Copyright: © 2019 Nigerian Medical Journal http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Jain, Prachi
Bhosale, Uma A.
Soundattikar, Girish
A Randomized Controlled Trial to Compare Preemptive Analgesic Efficacy and Safety of Pregabalin and Gabapentin for Succinylcholine-Induced Myalgia
title A Randomized Controlled Trial to Compare Preemptive Analgesic Efficacy and Safety of Pregabalin and Gabapentin for Succinylcholine-Induced Myalgia
title_full A Randomized Controlled Trial to Compare Preemptive Analgesic Efficacy and Safety of Pregabalin and Gabapentin for Succinylcholine-Induced Myalgia
title_fullStr A Randomized Controlled Trial to Compare Preemptive Analgesic Efficacy and Safety of Pregabalin and Gabapentin for Succinylcholine-Induced Myalgia
title_full_unstemmed A Randomized Controlled Trial to Compare Preemptive Analgesic Efficacy and Safety of Pregabalin and Gabapentin for Succinylcholine-Induced Myalgia
title_short A Randomized Controlled Trial to Compare Preemptive Analgesic Efficacy and Safety of Pregabalin and Gabapentin for Succinylcholine-Induced Myalgia
title_sort randomized controlled trial to compare preemptive analgesic efficacy and safety of pregabalin and gabapentin for succinylcholine-induced myalgia
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676998/
https://www.ncbi.nlm.nih.gov/pubmed/31413432
http://dx.doi.org/10.4103/nmj.NMJ_9_19
work_keys_str_mv AT jainprachi arandomizedcontrolledtrialtocomparepreemptiveanalgesicefficacyandsafetyofpregabalinandgabapentinforsuccinylcholineinducedmyalgia
AT bhosaleumaa arandomizedcontrolledtrialtocomparepreemptiveanalgesicefficacyandsafetyofpregabalinandgabapentinforsuccinylcholineinducedmyalgia
AT soundattikargirish arandomizedcontrolledtrialtocomparepreemptiveanalgesicefficacyandsafetyofpregabalinandgabapentinforsuccinylcholineinducedmyalgia
AT jainprachi randomizedcontrolledtrialtocomparepreemptiveanalgesicefficacyandsafetyofpregabalinandgabapentinforsuccinylcholineinducedmyalgia
AT bhosaleumaa randomizedcontrolledtrialtocomparepreemptiveanalgesicefficacyandsafetyofpregabalinandgabapentinforsuccinylcholineinducedmyalgia
AT soundattikargirish randomizedcontrolledtrialtocomparepreemptiveanalgesicefficacyandsafetyofpregabalinandgabapentinforsuccinylcholineinducedmyalgia